54024-22-5
Hormone
C22H30O
310.5 g/mol
Amorphous
Commercial
Ready
Ready
Desogestrel is a progestin medication which is used in birth control pills for women. It is also used in the treatment of menopausal symptoms in women. Desogestrel is used alone in progestogen-only pills, known as "mini pills" and in combination with the estrogen ethinylestradiol in combined oral contraceptive pills. Desogestrel is also the only newer-generation progestin with reduced androgenic activity that is used in such formulations. In addition to hormonal contraception, Desogestrel has been used in combination with estrogens such as estradiol as a component of menopausal hormone therapy. This drug has also been used in the treatment of endometriosis. Desogestrel can be used as monotherapy or in combination with other medicines. Desogestrel is administered through the oral route by way of film-coated tablet or via the injection route.
Desogestrel enters the cell passively and acts by binding selectively to the progesterone receptor and generating low androgenic activity. Its binding produces an effect like a transcription factor and thus, it produces modifications in the mRNA synthesis. The active metabolite of Desogestrel, etonogestrel, presents a combination of high progestational activity with minimal intrinsic androgenicity.
Ornet Pharmaceuticals, based out of Gujarat, India, is a leading manufacturer and global supplier of Desogestrel API. Driven by technically sound, research-oriented leaders, each with over 2 decades of hands-on experience, Ornet develops and manufactures a wide array of complex APIs catering to multiple categories in its product portfolio, such as anti-diabetics, blood related, hormones, etc. Ornet’s Desogestrel API is the result of the “Quality over Quantity” approach taken by the organization for all R&D and manufacturing practices. This approach, along with the strategically located manufacturing facility in Gujarat, allows for Ornet to be a primary source, both domestically and globally, for all API needs.
Products protected by valid patents are not offered for commercial sale in countries where the sale of such products constitutes patent infringement but are offered solely for uses reasonably related to the development and submission of information under a law regulating the manufacture, use or sale of drugs. It is within the buyer’s responsibility and liability to check the patent situation of the product in the imported market(s).